Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial
Clinical infectious diseases/Clinical infectious diseases (Online. University of Chicago. Press)